Skip to Content, Navigation, or Footer.
The Daily Cardinal Est. 1892
Monday, December 11, 2023
Washington University sues WARF over kidney drug patents

A federal court substantiated Washington University in St. Louis's belief that WARF had undervalued a patent the two institutions had shared since the 1990s.

WARF forced to pay $31.6 million after royalties breach

A federal district court has mandated that the Wisconsin Alumni Research Foundation, the university’s licensing and patenting arm, pay Washington University in St. Louis $31.6 million dollars for breaching a royalties contract related to selling a kidney disease drug.

Washington University and WARF both held rights to the drug when it was developed in the 1990s, but WARF licensed the patent to Illinois-based company Abbott Laboratories in 1998. In 2013, AbbVie, a spin-off company, continued to use the patent to manufacture the drug.

Washington University opened the lawsuit against WARF in 2013, alleging the organization had violated terms of a royalties agreement and undervalued terms of the patent.

“After Washington University learned through publicly available information that this patent had a very significant value, the university reached out to WARF to try to negotiate a resolution and WARF just refused to give the university the information it needed; so, we had to file suit,” Michael Jacobs, the lead counsel for Washington University,said last March.

Washington University representatives say they wish they had been able to reach a more amicable solution.

“We remain disappointed that WARF would not negotiate a resolution and that we had to resolve this matter through the court system,” Washington University spokeswoman Caroline Arbanas said in a statement.

As of Sunday, WARF has not issued a statement regarding the settlement.

Support your local paper
Donate Today
The Daily Cardinal has been covering the University and Madison community since 1892. Please consider giving today.

Powered by SNworks Solutions by The State News
All Content © 2023 The Daily Cardinal